The study, published in JAMA Pediatrics, examined data from 43,133 twin infants born at 34 weeks or after, between Jan. 1, 1980, and Dec. 31, 2015, in Scotland.
Of the 43,133 twin infants, 26,172 remained in utero for 37 weeks or more before being born.
Researchers found that twin born between the 34th and 37th week of pregnancy had higher odds of fetal death (stillbirth) or early neonatal death than twins who remained in utero for longer.
Researchers linked educational data for 9,519 twin children in the study and found that twins born before 37 weeks faced a higher risk of experiencing special educational needs while in school.
“In the absence of a medical complication, twins should not be routinely delivered before 37 completed weeks of gestation,” study authors concluded.
More articles on patient safety and outcomes:
Daily care team briefings cut hospital stays for lung disease patients
National taskforce recommends hepatitis C screening for all US adults
Civica Rx investor gives Penn Nursing $6M to study care model
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
